Zoledronic acid(ZOMETA): a significant improvement in the bone metastases.
Nagy
Zsuzsanna
Z
Department of Clinical Oncology, St. Imre Hopital, Budapest, Hungary.
D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary*; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D009362:Neoplasm Metastasis / Q000188:drug therapy; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid